Code | 3513D | ||||||||||
MA number | 07/0025/20-S | ||||||||||
Product Form: | cps mol 10x400 mg (blis.PVC/Al) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Mutual recognition procedure | ||||||||||
Therapeutic Class: | 07 - ANALGETICA, ANTIPYRETICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | blister PVC/Al transparent | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product not subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 04.02.2020 |
Validity: | 04.02.2025 |
MA renewed: | Renewal application submitted |
Pediatric indication: | Yes |
Pediatric posology: | Yes |
Pediatric warnings: | Yes |
SPC: | SPC_Ibuprofen Dr.Max 400 mg mäkké kapsuly_02.2024.pdf |
PIL: | PIL_Ibuprofen Dr.Max 400 mg mäkké kapsuly_02.2024.pdf |
Safety feature | No |
Data update: | 05.02.2020 |